Hostname: page-component-89b8bd64d-n8gtw Total loading time: 0 Render date: 2026-05-06T14:30:41.688Z Has data issue: false hasContentIssue false

Unveiling readability challenges: An extensive analysis of consent document accessibility in clinical trials

Published online by Cambridge University Press:  16 September 2024

Adrian H. Zai*
Affiliation:
Department of Population and Quantitative Health Science, University of Massachusetts Chan Medical School, Worcester, MA, USA
Jamie M. Faro
Affiliation:
Department of Population and Quantitative Health Science, University of Massachusetts Chan Medical School, Worcester, MA, USA
Jeroan Allison
Affiliation:
Department of Population and Quantitative Health Science, University of Massachusetts Chan Medical School, Worcester, MA, USA
*
Corresponding author: A. H. Zai; Email: adrian.zai@umassmed.edu
Rights & Permissions [Opens in a new window]

Abstract

Background:

Clinical research trials rely on informed consent forms (ICFs) to explain all aspects of the study to potential participants. Despite efforts to ensure the readability of ICFs, concerns about their complexity and participant understanding persist. There is a noted gap between Institutional Review Board (IRB) standards and the actual readability levels of ICFs, which often exceed the recommended 8th-grade reading level. This study evaluates the readability of over five thousand ICFs from ClinicalTrials.gov in the USA to assess their literacy levels.

Methods:

We analyzed 5,239 US-based ICFs from ClinicalTrials.gov using readability metrics such as the Flesch Reading Ease, Flesch-Kincaid Grade Level, Gunning Fog Index, and the percentage of difficult words. We examined trends in readability levels across studies initiated from 2005 to 2024.

Results:

Most ICFs exceeded the recommended 8th-grade reading level, with an average Flesch-Kincaid Grade Level of 10.99. While 91% of the ICFs were written above the 8th-grade level, there was an observable improvement in readability, with fewer studies exceeding a 10th-grade reading level in recent years.

Conclusions:

The study reveals a discrepancy between the recommended readability levels and actual ICFs, highlighting a need for simplification. Despite a trend toward improvement in more recent years, ongoing efforts are necessary to ensure ICFs are comprehensible to participants of varied educational backgrounds, reinforcing the ethical integrity of the consent process.

Information

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of Association for Clinical and Translational Science
Figure 0

Figure 1. Flow diagram of study selection process. ICF = informed consent form.

Figure 1

Table 1. Characteristics clinical trials informed consent forms (ClinicalTrials.gov, 2005–2024, n = 5239)

Figure 2

Table 2. Comparative analysis of readability metrics (ClinicalTrials.gov, 2005–2024, n = 5239)

Figure 3

Figure 2. Distribution of Flesch-Kincaid Grade Level scores aggregated by year (ClinicalTrials.gov, 2005–2024, n = 5239).

Figure 4

Figure 3. Trends in clinical study readability: comparison of studies with ≥8 vs. ≥10 Flesch-Kincaid Grade Levels (ClinicalTrials.gov, 2010–2020, n = 3925).

Figure 5

Figure 4. Four-year interval trends in the percent of clinical studies exceeding Flesch-Kincaid Grade Level thresholds (ClinicalTrials.gov, 2005–2024, n = 5,239).

Supplementary material: File

Zai et al. supplementary material

Zai et al. supplementary material
Download Zai et al. supplementary material(File)
File 829.1 KB